Inherited forms of renal hypomagnesemia: An update

Pediatric Nephrology

Volumn 24, Issue 4, 2009, Pages 697-705

  Knoers, Nine V A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Claudins; EGF; Gitelman syndrome; Hypomagnesemia; Mg2+; Na K ATPase subunit; NCC; TRPM6

Indexed keywords

ALDOSTERONE ANTAGONIST; AMILORIDE; AMINOGLYCOSIDE DERIVATIVE; CETUXIMAB; CITRIC ACID; CLAUDIN; DIURETIC AGENT; EPIDERMAL GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; ION CHANNEL; MAGNESIUM; MAGNESIUM ASPARTATE; MAGNESIUM CHLORIDE; MAGNESIUM OXIDE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHLORIDE COTRANSPORTER; THIAZIDE DIURETIC AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL MELASTATIN 6; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CHILD; DIARRHEA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG MEGADOSE; FAMILIAL DISEASE; FAMILIAL HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS; FAMILIAL HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA; GENE MUTATION; GENETIC DISORDER; GITELMAN SYNDROME; HENLE LOOP; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; KIDNEY CALCIFICATION; KIDNEY DISEASE; KIDNEY DISTAL TUBULE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; MOLECULAR CLONING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RENAL HYPOMAGNESEMIA WITH HYPOCALCIURIA; REVIEW; TISSUE DISTRIBUTION;

GITELMAN SYNDROME; HUMANS; HYPOCALCEMIA; KIDNEY; KIDNEY TUBULES; MAGNESIUM; MAGNESIUM DEFICIENCY; METAL METABOLISM, INBORN ERRORS; TRPM CATION CHANNELS;

EID: 61649115626     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0968-x     Document Type: Review

References (60)

1. 2+ absorption. J Biol Chem 279:19-25
2. Tejpar S, Piessevaux H, Claes K, Piront P, Hoenderop JG, Verslype C, Van Cutsem E (2007) Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: A prospective study. Lancet Oncol 8:387-394
3. Praga M, Vara J, González-Parra E, Andrés A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419-1425
4. Manz F, Scharer K, Janka P, Lombeck J (1978) Renal magnesium wasting, incomplete tubular acidosis, hypercalciuria, and nephrocalcinosis in siblings. Eur J Pediatr 128:67-79
5. Evans RA, Carter JN, George CR, Walls RS, Newland RC, McDonnell GD, Lawrence JR (1981) The congenital "magnesium-loosing kidney". Report of two patients. QJM 50:39-52
6. Benigno V, Canonica CS, Bettinelli A, von Vigier RO (2000) Hypomagnesemia-hypercalciuria-nephrocalcinosis: A report of nine cases and a review. Nephrol Dial Transplant 15:605-610
7. Michelis MF, Drash AL, Linarelli LG, De Rubertis FR, Davis BB (1972) Decreased bicarnonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis: Evaluation of the pathophysiological role of parathyroid hormone. Metabolism 21:905-920
8. Rodriguez-Soriano J, Vallo A (1994) Pathophysiology of the renal acidification defect present in the syndrome of familial hypomagnesemia-hypercalciuria. Pediatr Nephrol 8:431-435
9. Ulmann A, Hadj S, Lacour B, Bourdeau A, Bader C (1985) Renal magnesium and phosphate wastage in a patient with hypercalciuria and nephrocalcinosis: Effect of oral phosphorus and magnesium supplements. Nephron 40:83-87
10. Rodriguez-Soriano J, Vallo A, Garcai-Fuentes M (1987) Hypomagnesemia of hereditary renal origin. Pediatr Nephrol 1:465-471
11. Weber S, Schneider L, Peters M, Misselwitz J, Rönnefarth G, Böswald M, Bonzel KE, Seeman T, Suláková T, Kuwertz-Bröking E, Gregoric A, Palcoux JB, Tasic V, Manz F, Schärer K, Seyberth HW, Konrad M (2001) Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 12:1872-1881
12. Kang JH, Choi HJ, Cho HY, Lee JH, Sa IS, Cheig HI, Choi Y (2005) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations. Pediatr Nephrol 20:1490-1493
13. 2+ resorption. Science 285:103-106
14. Konrad M, Hou J, Weber S, Dötsch J, Kari JA, Seeman T, Kuwertz-Bröking E, Peco-Antic A, Tasic V, Dittrich K, Alshaya HO, von Vigier RO, Gallati S, Goodenough DA, Schaller A (2008) CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 19:171-181
15. Morita K, Furuse M, Fukimoto K, Tsukita S (1999) Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 96:511-516
16. Muller D, Kausalya J, Claverie-Martin F, Meij IC, Eggert P, Garcia-Nieto V, Hunziker W (2003) A novel claudin 16 mutation associated with childhood hypercalciuria abolished binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 73:1293-1301
17. Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, Lesslauer A, Vitzthum H, Suzuki Y, Luk JM, Becker C, Schlingmann KP, Schmid M, Rodriguez-Soriano J, Ariceta G, Cano F, Enriquez R, Juppner H, Bakkaloglu SA, Hediger MA, Gallati S, Neuhauss SC, Nurnberg P, Weber S (2006) Mutations in the tight junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79:949-957
18. Hou J, Paul DL, Goodenough DA (2005) Paracellin-1 and the modulation of ion selectivity of tight junctions. J Cell Sci 118:5109-5118
19. Hou J, Shan Q, Wang T, Gomes AS, Yan Q, Paul DL, Bleigh M, Goodenough DA (2007) Transgenic RNAi depletion of claudin-16 and the renal handling of magnesium. J Biol Chem 282:17114-17122
20. Gitelman HJ, Graham JB, Welt LG (1966) A familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 79:221-235
21. Melander O, Ohro-Melander M, Bengtsson K, Lindblad U, Rastam L, Groop L, Hulthen UL (2000) Genetic variants of thiazide-senstive NaCl cotransporter in Gitelman's syndrome and primary hypertension. Hypertension 36:389-394
22. Riveira-Munoz E, Chang Q, Godefroid N, Hoenderop JG, Bindels RJ, Dahan K, Devuyst O (2007) Belgian Network for Study of Gitelman Syndrome. Transcriptional and functional analyses of SLC12A3 mutations: New clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol 1:1271-1283
23. Caló L, Punzi L, Semplicini A (2000) Hypomagnesemia and chondrocalcinosis in Bartter's and Gitelman's syndrome: Review of the pathogenetic mechanisms. Am J Nephrol 20:347-350
24. Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB (2001) Gitelman's syndrome revisited: An evaluation of symptoms and health-related quality of life. Kidney Int 59:710-717
25. Foglia PEG, Bettineli A, Tosetto C, Cortesi C, Crosazzo L, Edefonti A, Bianchetti MG (2004) Cardiac work up in primary hypokalemia-hypomagnesemia (Gitelman syndrome). Nephrol Dial Transplant 19:1398-1402
26. Scognamiglio R, Negut C, Calò LA (2007) Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes. Clin Nephrol 67:193-197
27. Fava C, Montagnana M, Rosberg L, Burri P, Almgren P, Jönsson A, Wanby P, Lippi G, Minuz P, Hulthèn LU, Aurell M, Melander O (2008) Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet 17:413-418
28. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP (2008) Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40:592-599
29. Cruz DN, Simon DB, Nelson-Williams C, Farhi A, Finberg K, Burleson L, Gill JR, Lifton RP (2001) Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 37:1458-1464
30. Lin SH, Cheng NL, Hsu YJ, Halperin ML (2004) Intrafamiliar phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter. Am J Kidney Dis 43:304-312
31. Firoz M, Braber M (2001) Bioavailability of U.S. commercial magnesium preparations. Magnesium Res 4:257-262
32. Bonfante L, Davis PA, Spinello M, Antonello A, D'Angelo A, Semplicini A, Galo L (2001) Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome. Am J Kidney Dis 38:165-168
33. Knoers NVAM, Starremans PGJF, Monnens LAH (2005) Hypokalemic tubular disorders. In Davidson AM, Cameron JS, Grunfeld J-P, Ponticelli C, Ritz E, Winearls CG, van Ypersele C (eds) Oxford textbook in clinical nephrology, 3rd edn. Oxford University Press, Oxford, pp 995-1004
34. Gamba G, Saltzberg SN, Lombardi M, Miyanoshita A, Lytton J, Hediger MA, Brenner BM, Hebert SC (1993) Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci USA 90:2749-2753
35. de Jong JC, van der Vliet WA, van den Heuvel LPWJ, Willems PHGM, Knoers NVAM, Bindels RJM (2002) Functional expression of mutations in the human NaCl cotransporter (NCC): Evidence for impaired routing mechanisms in Gitelman's syndrome. J Am Soc Nephrol 13:1442-1448
36. de Jong JC, Willems PHGM, Mooren FJM, van den Heuvel PWJ, Knoers NVAM, Bindels RJM (2003) The structural unit of the thiazide-sensitive NaCl cotransporter (NCC) is a homodimer. J Biol Chem 278:24302-24307
37. Sabath E, Meade P, Berkman J, de los Heros P, Moreno E, Bobadilla NA, Vazquez N, Ellison DH, Gamba G (2004) Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease. Am J Physiol Renal Physiol 287:F195-F203
38. Riveira-Munoz E, Chang Q, Bindels RJ, Devuyst O (2007) Gitelman's syndrome: Towards genotype-phenotype correlations? Pediatr Nephrol 22:326-332
39. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17:171-178
40. Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A, Ruf R, Deschênes G, Antignac C, Guay-Woodford L, Knoers NV, Seyberth HW, Feldmann D, Hildebrandt F (2000) Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 11:1449-1459
41. 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115:1651-1658
42. Geven WB, Monnens LA, Willems HL, Buijs WC, ter Haar BG (1987) Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int 31:1140-1144
43. Meij IC, Koenderink JB, van Bokhoven H, Assink KFH, Tiel Groenestege W, de Pont JJHHM, Bindels RJM, Monnens LAH, van den Heuvel LPWJ, Knoers NVAM (2000) Dominant isolated renal magnesium loss is caused by misrouting of the Na(+), K(+)-ATPase gamma subunit. Nat Genet 26:265-266
44. + affinity of the renal Na,K-ATPase. J Biol Chem 274:33183-33185
45. Meij IC, Koenderink JB, De Jong JC, De Pont JJ, Monnens LA, Van Den Heuvel LP, Knoers NV (2003) Dominant isolated renal magnesium loss is caused by misrouting of the Na,K, ATPase gamma subunit. Ann NY Acad Sci 986:437-443
46. + affinity and decreased thermal stability. J Biol Chem 280:19003-19011
47. 2+ channels in health and disease. J Am Soc Nephrol 16:15-26
48. Kantorovich V, Adams JS, Gaines JE, Guo X, Pandian M, Cohn D, Rude R (2002) Genetic heterogeneity in familial renal magnesium wasting. J Endocrinol Metab 87:612-617
49. Paunier L, Radde IC, Kooh SW, Conen PE, Fraser D (1968) Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 41:385-402
50. Anast CS, Mohs JM, Kaplan SL, Bruns TW (1972) Evidence for parathyroid failure in magnesium deficiency. Science 177:606-608
51. Schlingmann KP, Sassen MC, Weber S, Pechmann U, Kusch K, Pelken L, Lotan D, Syrrou M, Prebble JJ, Cole DEC, Metger DL, Rahman S, Tajima T, Shu S-G, Waldegger S, Seyberth HW, Konrad M (2005) Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc Nephrol 16:3061-3069
52. Shalev H, Phillip M, Galil A, Carmi R, Landau D (1998) Clinical presentation and outcome in primary familial hypomagnesemia. Arch Dis Child 78:127-130
53. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M (2002) Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31:166-170
54. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC (2002) Mutation of the TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31:171-174
55. Clapham DE (2003) TRP channels as cellular sensors. Nature 426:517-524
56. Geven WB, Monnens LA, Willems JL, Buijs W, Hamel BCJ (1987) Isolated autosomal recessive renal magnesium loss in two sisters. Clin Genet 32:398-402
57. Groenestege WM, Thebault S, van der Wijst J, van den Berg D, Janssen R, Tejpar S, van den Heuvel LP, van Cutsem E, Hoenderop JG, Knoers NV, Bindels RJ (2007) Impaired basolateral sorting of the pro-EGF causes isolated renal hypomagnesemia. J Clin Invest 117:2260-2267
58. Bell GI, Fong NM, Stempien MM, Wormsted MA, Caput D, Ku LL, Urdea MS, Rall LB, Sanchez-Pescador R (1986) Human epidermal growth factor precursor: CDNA sequence, expression in vitro and gene organization. Nucleic Acids Res 14:8427-8446
59. Loffing J, Loffing-Cueni D, Valderrabano V, Kläusli L, Hebert SC, Rossier BC, Hoenderop JG, Bindels RJ, Kaissling B (2001) Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol 281:F1021-F1027
60. Dempsey PJ, Meisse KS, Yoshitake Y, Nishikawa K, Coffey RJ (1997) Apical enrichment of human EGF precursor on Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to metalloprotease inhibitor. J Cell Biol 138:747-758